Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Effectiveness and safety of daptomycin in patients with infective endocarditis undergoing heart valve replacement: a subgroup analysis from real-world data.

Guleri A, Utili R, Dohmen P, Hamed K.

Ther Adv Infect Dis. 2017 Mar;4(2):41-47. doi: 10.1177/2049936117692297. Epub 2017 Feb 17.

2.

International experts' practice in the antibiotic therapy of infective endocarditis is not following the guidelines.

Tissot-Dupont H, Casalta JP, Gouriet F, Hubert S, Salaun E, Habib G, Fernandez-Gerlinger MP, Mainardi JL, Tattevin P, Revest M, Lucht F, Botelho-Nevers E, Gagneux-Brunon A, Snygg-Martin U, Chan KL, Bishara J, Vilacosta I, Olmos C, San Román JA, López J, Tornos P, Fernández-Hidalgo N, Durante-Mangoni E, Utili R, Paul M, Baddour LM, DeSimone DC, Sohail MR, Steckelberg JM, Wilson WR, Raoult D.

Clin Microbiol Infect. 2017 Oct;23(10):736-739. doi: 10.1016/j.cmi.2017.03.007. Epub 2017 Mar 18.

3.

Electrophysiological Adverse Effects of Direct Acting Antivirals in Patients With Chronic Hepatitis C.

Durante-Mangoni E, Parrella A, Vitrone M, Rago A, Pafundi PC, Nigro G, Utili R, Russo V.

J Clin Pharmacol. 2017 Jul;57(7):924-930. doi: 10.1002/jcph.872. Epub 2017 Jan 24.

PMID:
28117887
4.

Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition.

Harris PNA, McNamara JF, Lye DC, Davis JS, Bernard L, Cheng AC, Doi Y, Fowler VG Jr, Kaye KS, Leibovici L, Lipman J, Llewelyn MJ, Munoz-Price S, Paul M, Peleg AY, Rodríguez-Baño J, Rogers BA, Seifert H, Thamlikitkul V, Thwaites G, Tong SYC, Turnidge J, Utili R, Webb SAR, Paterson DL.

Clin Microbiol Infect. 2017 Aug;23(8):533-541. doi: 10.1016/j.cmi.2016.10.023. Epub 2016 Nov 1. Review.

5.

Clinical significance of hyperhomocysteinemia in infective endocarditis: A case-control study.

Iossa D, Molaro R, Andini R, Parrella A, Ursi MP, Mattucci I, De Vincentiis L, Dialetto G, Utili R, Durante-Mangoni E.

Medicine (Baltimore). 2016 Sep;95(39):e4972. doi: 10.1097/MD.0000000000004972.

6.

Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections.

Durante-Mangoni E, Andini R, Signoriello S, Cavezza G, Murino P, Buono S, De Cristofaro M, Taglialatela C, Bassetti M, Malacarne P, Petrosillo N, Corcione A, Viscoli C, Utili R, Gallo C.

Clin Microbiol Infect. 2016 Dec;22(12):984-989. doi: 10.1016/j.cmi.2016.08.004. Epub 2016 Aug 18.

7.

Viability of pegIFNα-RBV for CHC in the direct acting antiviral era: a practical algorithm between efficacy and cost containment.

Pafundi PC, Parrella A, Iossa D, Molaro R, Battimelli C, Falco E, Sodano G, Utili R, Durante-Mangoni E.

J Chemother. 2017 Apr;29(2):94-101. doi: 10.1080/1120009X.2016.1171467. Epub 2016 Jun 28.

PMID:
27351356
8.

Safety of treatment with high-dose daptomycin in 102 patients with infective endocarditis.

Durante-Mangoni E, Andini R, Parrella A, Mattucci I, Cavezza G, Senese A, Trojaniello C, Caprioli R, Diana MV, Utili R.

Int J Antimicrob Agents. 2016 Jul;48(1):61-68. doi: 10.1016/j.ijantimicag.2016.04.022. Epub 2016 May 25.

PMID:
27259674
9.

Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipients.

Durante-Mangoni E, Vitrone M, Parrella A, Andini R, Iossa D, Ragone E, Falco E, Maiello C, Utili R, Zampino R.

Transpl Infect Dis. 2016 Jun;18(3):319-25. doi: 10.1111/tid.12525. Epub 2016 May 10.

PMID:
26988401
10.

Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents.

Syriopoulou V, Dailiana Z, Dmitriy N, Utili R, Pathan R, Hamed K.

Pediatr Infect Dis J. 2016 May;35(5):511-6. doi: 10.1097/INF.0000000000001076.

11.

Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort.

Durante-Mangoni E, Pafundi PC, Ravasio V, Barbaro F, Bassetti M, Chinello P, Falcone M, Pasticci MB, Scotton PG, Stellini R, Tripodi MF, Utili R, Rizzi M.

Infection. 2016 Aug;44(4):467-74. doi: 10.1007/s15010-015-0870-y. Epub 2016 Jan 19.

PMID:
26780903
12.

Infective endocarditis in patients with hepatic diseases.

Seminari E, De Silvestri A, Ravasio V, Ludovisi S, Utili R, Petrosillo N, Castelli F, Bassetti M, Barbaro F, Grossi P, Barzaghi N, Rizzi M, Minoli L.

Eur J Clin Microbiol Infect Dis. 2016 Feb;35(2):279-84. doi: 10.1007/s10096-015-2541-4. Epub 2015 Dec 21.

PMID:
26690071
13.

Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE).

Guleri A, Utili R, Dohmen P, Petrosillo N, Piper C, Pathan R, Hamed K.

Infect Dis Ther. 2015 Sep;4(3):283-96. doi: 10.1007/s40121-015-0075-9. Epub 2015 Jul 14.

14.

Effect of the immunosuppressive regimen on the incidence of cytomegalovirus infection in 378 heart transplant recipients: A single centre, prospective cohort study.

Durante-Mangoni E, Andini R, Pinto D, Iossa D, Molaro R, Agrusta F, Casillo R, Grimaldi M, Utili R.

J Clin Virol. 2015 Jul;68:37-42. doi: 10.1016/j.jcv.2015.04.017. Epub 2015 Apr 22.

PMID:
26071333
15.

Recipient-born bloodstream infection due to extensively drug-resistant Acinetobacter baumannii after emergency heart transplant: report of a case and review of the literature.

Andini R, Agrusta F, Mattucci I, Malgeri U, Cavezza G, Utili R, Durante-Mangoni E.

Infection. 2015 Oct;43(5):609-13. doi: 10.1007/s15010-015-0772-z. Epub 2015 Apr 1. Review.

PMID:
25828937
16.

Prevalence and significance of two major inherited thrombophilias in infective endocarditis.

Durante-Mangoni E, Iossa D, Molaro R, Andini R, Mattucci I, Malgeri U, Albisinni R, Utili R.

Intern Emerg Med. 2015 Aug;10(5):587-94. doi: 10.1007/s11739-015-1214-8. Epub 2015 Feb 25.

PMID:
25711313
17.

Differential antiviral effects of pegylated interferon-α2a and pegylated interferon-α2b in chronic hepatitis C.

Durante-Mangoni E, Parrella A, Iossa D, Andini R, Molaro R, Battimelli C, Sodano G, Utili R.

Clin Drug Investig. 2014 Dec;34(12):871-8. doi: 10.1007/s40261-014-0241-y.

PMID:
25349040
18.

Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date.

Durante-Mangoni E, Utili R, Zarrilli R.

Future Microbiol. 2014;9(6):773-89. doi: 10.2217/fmb.14.34. Review.

PMID:
25046524
19.

Nosocomial endocarditis: still a challenging diagnosis.

Durante-Mangoni E, Utili R.

Intern Emerg Med. 2014 Oct;9(7):715-6. doi: 10.1007/s11739-014-1105-4. Epub 2014 Jul 13. No abstract available.

PMID:
25016330
20.

Infective endocarditis due to multidrug resistant gram-negative bacilli: single centre experience over 5 years.

Durante-Mangoni E, Andini R, Agrusta F, Iossa D, Mattucci I, Bernardo M, Utili R.

Eur J Intern Med. 2014 Sep;25(7):657-61. doi: 10.1016/j.ejim.2014.05.015. Epub 2014 Jun 19.

PMID:
24954705
21.

Management of immunosuppression and antiviral treatment before and after heart transplant for HIV-associated dilated cardiomyopathy.

Durante-Mangoni E, Maiello C, Limongelli G, Sbreglia C, Pinto D, Amarelli C, Pacileo G, Perrella A, Agrusta F, Romano G, Marra C, Di Giambenedetto S, Nappi G, Utili R.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1):113-20.

PMID:
24674686
22.
23.

Reply to Huang et al.

Utili R, Durante-Mangoni E.

Clin Infect Dis. 2014 Jan;58(1):142-3. doi: 10.1093/cid/cit635. Epub 2013 Sep 30. No abstract available.

PMID:
24081684
24.

Clinico-pathological significance of hepatitis C virus core antigen levels in chronic infection.

Durante-Mangoni E, Vallefuoco L, Sorrentino R, Iossa D, Perna E, Molaro R, Braschi U, Zampino R, Sodano G, Adinolfi LE, Utili R, Portella G.

J Med Virol. 2013 Nov;85(11):1913-8. doi: 10.1002/jmv.23672. Epub 2013 Jul 29.

PMID:
23897630
25.

Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.

Durante-Mangoni E, Signoriello G, Andini R, Mattei A, De Cristoforo M, Murino P, Bassetti M, Malacarne P, Petrosillo N, Galdieri N, Mocavero P, Corcione A, Viscoli C, Zarrilli R, Gallo C, Utili R.

Clin Infect Dis. 2013 Aug;57(3):349-58. doi: 10.1093/cid/cit253. Epub 2013 Apr 24.

PMID:
23616495
26.

Adefovir treatment for chronic hepatitis B in heart transplant recipients.

Durante-Mangoni E, Iossa D, Pinto D, Molaro R, Agrusta F, Amarelli C, Ragone E, Grimaldi M, Maiello C, Utili R.

Clin Transplant. 2013 May-Jun;27(3):E282-8. doi: 10.1111/ctr.12109. Epub 2013 Mar 21.

PMID:
23517019
27.

Daptomycin for the treatment of infective endocarditis: results from a European registry.

Dohmen PM, Guleri A, Capone A, Utili R, Seaton RA, González-Ramallo VJ, Pathan R, Heep M, Chaves RL.

J Antimicrob Chemother. 2013 Apr;68(4):936-42. doi: 10.1093/jac/dks467. Epub 2012 Nov 28.

PMID:
23190763
28.

Current trends in the management of cardiac implantable electronic device (CIED) infections.

Durante-Mangoni E, Mattucci I, Agrusta F, Tripodi MF, Utili R.

Intern Emerg Med. 2013 Sep;8(6):465-76. doi: 10.1007/s11739-012-0797-6. Epub 2012 Jun 29. Review.

PMID:
22744804
29.

Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis.

Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG, Barzaghi N, Falcone M, Chinello P, Pasticci MB, Grossi P, Utili R, Viale P, Rizzi M, Suter F.

Infection. 2012 Oct;40(5):527-35. doi: 10.1007/s15010-012-0285-y. Epub 2012 Jun 19.

PMID:
22711599
30.

Clinical experience with daptomycin in Italy: results from a registry study of the treatment of Gram-positive infections between 2006 and 2009.

Utili R, Cogo A, Cristini F, Prisco V, Sagnelli E, Tascini C, Iacoboni C, Capone A, Gattuso G, Angarano G, Petrelli E, Grossi P, Bartezaghi M, Zagni E.

J Chemother. 2012 Apr;24(2):113-21. doi: 10.1179/1120009X12Z.00000000023.

PMID:
22546768
31.

[Management of infections from cardiac implantable electronic devices: recommendations from a study panel].

Durante Mangoni E, Carbonara S, Iacobello C, Tripodi MF, Carretta A, Caprioli V, Pellegrino P, Di Biase M, Favale S, Santantonio TA, Esposito S, Nappi G, Angarano G, Utili R.

Infez Med. 2011 Dec;19(4):207-23. Review. Italian.

32.

Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.

Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A.

JAMA. 2011 Nov 23;306(20):2239-47. doi: 10.1001/jama.2011.1701.

33.

High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis.

Durante-Mangoni E, Casillo R, Bernardo M, Caianiello C, Mattucci I, Pinto D, Agrusta F, Caprioli R, Albisinni R, Ragone E, Utili R.

Clin Infect Dis. 2012 Feb 1;54(3):347-54. doi: 10.1093/cid/cir805. Epub 2011 Nov 18.

PMID:
22100575
34.

Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy.

Giannouli M, Di Popolo A, Durante-Mangoni E, Bernardo M, Cuccurullo S, Amato G, Tripodi MF, Triassi M, Utili R, Zarrilli R.

Int J Antimicrob Agents. 2012 Jan;39(1):58-63. doi: 10.1016/j.ijantimicag.2011.09.016. Epub 2011 Nov 3.

PMID:
22055530
35.

Inherited hyper-homocysteinemia as a cause of nonbacterial thrombotic endocarditis.

Durante-Mangoni E, Iossa D, Nappi F, Utili R.

J Heart Valve Dis. 2011 Mar;20(2):232-3.

PMID:
21560828
36.

Heart transplantation during active infective endocarditis: case report and review of the literature.

Durante-Mangoni E, Casillo R, Pinto D, Caianiello C, Albisinni R, Caprioli V, Maiello C, Utili R.

Transplant Proc. 2011 Jan-Feb;43(1):304-6. doi: 10.1016/j.transproceed.2010.09.095. Review.

PMID:
21335210
37.

Outcome of treatment with pegylated interferon and ribavirin in heart transplant recipients with chronic hepatitis C.

Durante-Mangoni E, Ragone E, Pinto D, Iossa D, Covino FE, Maiello C, Utili R.

Transplant Proc. 2011 Jan-Feb;43(1):299-303. doi: 10.1016/j.transproceed.2010.09.096.

PMID:
21335209
38.

Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease.

Durante-Mangoni E, Iossa D, Pinto D, De Vincentiis L, Ragone E, Utili R.

Dig Liver Dis. 2011 May;43(5):411-5. doi: 10.1016/j.dld.2010.12.011.

PMID:
21310673
39.

In vitro activity of multiple antibiotic combinations against Nocardia: relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis.

Tripodi MF, Durante-Mangoni E, Fortunato R, Cuccurullo S, Mikami Y, Farina C, Utili R.

Transpl Infect Dis. 2011 Aug;13(4):335-43. doi: 10.1111/j.1399-3062.2010.00588.x. Epub 2010 Dec 13.

PMID:
21156012
40.

Management of Gram-negative and fungal endocarditis.

Durante-Mangoni E, Tripodi MF, Albisinni R, Utili R.

Int J Antimicrob Agents. 2010 Dec;36 Suppl 2:S40-5. doi: 10.1016/j.ijantimicag.2010.11.012. Epub 2010 Dec 3. Review.

PMID:
21129927
41.

Yellow nail syndrome as a cause of unexplained edema.

Cimini C, Giunta R, Utili R, Durante-Mangoni E.

Monaldi Arch Chest Dis. 2009 Dec;71(4):176-9.

PMID:
20440922
42.

Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone.

Giannouli M, Cuccurullo S, Crivaro V, Di Popolo A, Bernardo M, Tomasone F, Amato G, Brisse S, Triassi M, Utili R, Zarrilli R.

J Clin Microbiol. 2010 Apr;48(4):1223-30. doi: 10.1128/JCM.02263-09. Epub 2010 Feb 24.

43.

[Treatment of multiresistant Gram positive endocarditis].

Utili R.

Infez Med. 2009 Jul;17 Suppl 3:13-24. Italian.

44.

The prophylaxis of infective endocarditis: a joint position study of the Italian Federation of Cardiologists and the Italian Society of Infectious and Tropical Diseases.

Cecchi E, De Rosa FG, Chirillo F, Petrelli E, Oreto G, Suter F, Lagioia R, Viale P, Enia F, Bassetti M, Venditti M, Petrosillo N, Utili R, Imazio M, Trinchero R.

J Cardiovasc Med (Hagerstown). 2010 Jun;11(6):419-25. doi: 10.2459/JCM.0b013e328333927c. Review.

PMID:
19910799
45.

Long-term outcome of hepatitis B and hepatitis C virus co-infection and single HBV infection acquired in youth.

Zampino R, Marrone A, Merola A, Trani B, Cirillo G, Karayiannis P, Coppola N, Zappalà R, Utili R, Ruggiero G, Adinolfi LE.

J Med Virol. 2009 Dec;81(12):2012-20. doi: 10.1002/jmv.21560.

PMID:
19856471
46.

[Novel clinical and epidemiologic trends in elderly infective endocarditis].

Durante Mangoni E, Utili R.

Recenti Prog Med. 2009 Jun;100(6):307-10. Italian.

PMID:
19708302
47.

[Prophylaxis of infective endocarditis. Joint position paper of the Italian Federation of Cardiology and the Italian Society of Infectious and Tropical Diseases].

Cecchi E, De Rosa FG, Chirillo F, Petrelli E, Oreto G, Suter F, Lagioia R, Viale P, Enia F, Bassetti M, Venditti M, Petrosillo N, Utili R, Imazio M; Italian Federation of Cardiology; Italian Society of Infectious and Tropical Diseases.

G Ital Cardiol (Rome). 2009 Jun;10(6):395C-400C. Review. Italian. No abstract available.

PMID:
19603610
48.

Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics during treatment.

Durante-Mangoni E, Zampino R, Portella G, Adinolfi LE, Utili R, Ruggiero G.

Clin Infect Dis. 2009 Aug 15;49(4):498-506. doi: 10.1086/600887.

PMID:
19591593
49.

Rhodococcus equi endocarditis in immunocompetent hosts: report of the first two cases.

Tripodi MF, Vigo D, Durante-Mangoni E, Lifschitz A, Corey GR, Stryjewski ME, Utili R, Pryluka D; International Collaboration on Endocarditis Prospective Cohort Study.

Int J Antimicrob Agents. 2009 Nov;34(5):496-7. doi: 10.1016/j.ijantimicag.2009.06.002. Epub 2009 Jul 9. No abstract available.

PMID:
19589660
50.

Candida infective endocarditis: report of 15 cases from a prospective multicenter study.

Falcone M, Barzaghi N, Carosi G, Grossi P, Minoli L, Ravasio V, Rizzi M, Suter F, Utili R, Viscoli C, Venditti M; Italian Study on Endocarditis.

Medicine (Baltimore). 2009 May;88(3):160-8. doi: 10.1097/MD.0b013e3181a693f8.

Supplemental Content

Support Center